Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
about
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sequential high-dose ifosfamid ...... in progression-free survival.
@ast
Sequential high-dose ifosfamid ...... in progression-free survival.
@en
type
label
Sequential high-dose ifosfamid ...... in progression-free survival.
@ast
Sequential high-dose ifosfamid ...... in progression-free survival.
@en
prefLabel
Sequential high-dose ifosfamid ...... in progression-free survival.
@ast
Sequential high-dose ifosfamid ...... in progression-free survival.
@en
P2093
P2860
P1433
P1476
Sequential high-dose ifosfamid ...... in progression-free survival.
@en
P2093
Anne W Beaven
David A Rizzieri
Dominic T Moore
Don A Gabriel
Jon P Gockerman
Nelson Chao
Reynaldo A Garcia
Thomas C Shea
P2860
P304
P356
10.1080/10428190902853136
P577
2009-05-01T00:00:00Z